65 related articles for article (PubMed ID: 6277193)
1. Control mechanisms in platelet activation.
Fritsma G; Engelmann G; Yousuf M
Am J Med Technol; 1981 Oct; 47(10):813-8. PubMed ID: 6277193
[TBL] [Abstract][Full Text] [Related]
2. [Mechanisms of action of prostaglandins on the thrombocyte-vascular wall system].
Gabrielian ES; Akopov SE; Badzhinian SA
Vestn Akad Med Nauk SSSR; 1984; (11):63-8. PubMed ID: 6099016
[No Abstract] [Full Text] [Related]
3. The platelet dense tubular system: its relationship to prostaglandin synthesis and calcium flux.
Gerrard JM; White JG; Peterson DA
Thromb Haemost; 1978 Oct; 40(2):224-31. PubMed ID: 366793
[TBL] [Abstract][Full Text] [Related]
4. Regulation of cyclic AMP metabolism in human platelets. Sequential activation of adenylate cyclase and cyclic AMP phosphodiesterase by prostaglandins.
Alvarez R; Taylor A; Fazzari JJ; Jacobs JR
Mol Pharmacol; 1981 Sep; 20(2):302-9. PubMed ID: 6272089
[No Abstract] [Full Text] [Related]
5. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3.
Feijge MA; Ansink K; Vanschoonbeek K; Heemskerk JW
Biochem Pharmacol; 2004 Apr; 67(8):1559-67. PubMed ID: 15041473
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of aggregation and stimulation of cyclic AMP generation in intact human platelets by the diterpene forskolin.
Siegl AM; Daly JW; Smith JB
Mol Pharmacol; 1982 May; 21(3):680-7. PubMed ID: 6287202
[No Abstract] [Full Text] [Related]
7. Effects of quercetin on aggregation and intracellular free calcium of platelets.
Xiao D; Gu ZL; Bai JP; Wang Z
Zhongguo Yao Li Xue Bao; 1995 May; 16(3):223-6. PubMed ID: 7660815
[TBL] [Abstract][Full Text] [Related]
8. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
Bilodeau ML; Hamm HE
J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
[TBL] [Abstract][Full Text] [Related]
9. Effects of genistein on aggregation and cytosolic free calcium in pig platelets.
Liu W; Song ZJ; Liang NC
Zhongguo Yao Li Xue Bao; 1998 Nov; 19(6):540-2. PubMed ID: 10437141
[TBL] [Abstract][Full Text] [Related]
10. Cyclic nucleotides in hemostasis and thrombosis.
Steer ML; Salzman EW
Adv Cyclic Nucleotide Res; 1980; 12():71-92. PubMed ID: 6250376
[No Abstract] [Full Text] [Related]
11. Mechanisms of antiplatelet activity of PC-09, a newly synthesized pyridazinone derivative.
Cherng SC; Huang WH; Shiau CY; Lee AR; Chou TC
Eur J Pharmacol; 2006 Feb; 532(1-2):32-7. PubMed ID: 16457809
[TBL] [Abstract][Full Text] [Related]
12. [Mechanisms of the protease-induced aggregation of human platelets].
Chernovets TS; Mazhul' VN
Biofizika; 2007; 52(4):674-80. PubMed ID: 17907408
[TBL] [Abstract][Full Text] [Related]
13. Platelets, prostaglandins and thrombotic disorders.
de Gaetano G
Clin Haematol; 1981 Jun; 10(2):297-326. PubMed ID: 6274552
[No Abstract] [Full Text] [Related]
14. Inhibitory effect of GBH on platelet aggregation through inhibition of intracellular Ca2+ mobilization in activated human platelets.
Park WH; Kim HK; Nam KS; Shon YH; Jeon BH; Moon SK; Kim MG; Kim CH
Life Sci; 2004 Nov; 75(25):3063-76. PubMed ID: 15474558
[TBL] [Abstract][Full Text] [Related]
15. A new insight of anti-platelet effects of sirtinol in platelets aggregation via cyclic AMP phosphodiesterase.
Liu FC; Liao CH; Chang YW; Liou JT; Day YJ
Biochem Pharmacol; 2009 Apr; 77(8):1364-73. PubMed ID: 19426675
[TBL] [Abstract][Full Text] [Related]
16. [Acquired changes in platelet function].
Lucia JF
Sangre (Barc); 1984; 29(4-C):798-810. PubMed ID: 6096973
[No Abstract] [Full Text] [Related]
17. [Platelet physiology. Advances in platelet reactivity. Review].
Vizcaíno-Salazar G
Invest Clin; 1994 Mar; 35(1):41-62. PubMed ID: 8054381
[TBL] [Abstract][Full Text] [Related]
18. Splitomicin suppresses human platelet aggregation via inhibition of cyclic AMP phosphodiesterase and intracellular Ca++ release.
Liu FC; Liao CH; Chang YW; Liou JT; Day YJ
Thromb Res; 2009 Jun; 124(2):199-207. PubMed ID: 19327818
[TBL] [Abstract][Full Text] [Related]
19. 2-Aminochromones block human platelet aggregation by inhibiting cyclic AMP-dependent phosphodiesterase leading to reduced platelet phospholipase C activity.
Benjamin CW; Lin AH; Morris J; Wishka DG; Gorman RR
J Pharmacol Exp Ther; 1993 Apr; 265(1):457-62. PubMed ID: 7682615
[TBL] [Abstract][Full Text] [Related]
20. [Role of disorders of cyclic adenosine-3',5'--monophosphate (cAMP) in the pathogenesis of bronchial asthma].
Zhikharev SS
Ter Arkh; 1977; 49(3):131-5. PubMed ID: 67651
[No Abstract] [Full Text] [Related]
[Next] [New Search]
